The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.

To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.

For additional information please review our Privacy Policy.


Novel Mechanisms of Action in Adjuvant Therapy: Bisphosphonates and Targeted Agents in Solid Tumors


This presentation was selected by the American Society of Clinical Oncology® as an independent educational activity held in conjunction with an ASCO meeting. This presentation is not sponsored or endorsed by ASCO.

Novel Mechanisms of Action in Adjuvant Therapy: Bisphosphonates and Targeted Agents in Solid Tumors


Novel Mechanisms of Action in Adjuvant Therapy: Bisphosphonates and Targeted Agents in Solid Tumors - Opening Remarks
Speaker: Adam Brufsky

Expanding the Targets in Adjuvant Therapy
Speaker: Adam Brufsky

Clinical Data on the Use of Bisphosphonates in the Adjuvant Treatment of Breast Cancer
Speaker: Michael Gnant

Beyond Breast Cancer: An Update on Biophosphates for Prostate Cancer
Speaker: Matthew Smith

Interactive Dialogue Session: Clinical Considerations and Debates in Adjuvant Therapy





 
2318 Mill Road, Suite 800, Alexandria, VA 22314   |   phone: (571) 483-1300
© 2005-2009 American Society of Clinical Oncology (ASCO).  All rights reserved worldwide.